🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if tislelizumab in combination ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2025-07-20
Trial ID
NCT06977828
Treatments Being Tested
This is an observational prospective bi-center study of 50 patients operate...
Status
Unknown
Location
TianjinCIH
Start Date
2022-04-01
Trial ID
NCT05854030
Treatments Being Tested
The purpose of this study is to investigate the feasibility, safety, and lo...
Status
Unknown
Location
Institute of Hepatobiliary Surgery, Southwest Hospital,Third Military Medical University
Start Date
2005-05
Trial ID
NCT01291927
Treatments Being Tested
the purpose of the present registry is to describe the epidemiology of fore...
Status
Completed
Location
Manila Boarini
Start Date
2018-01-01
Trial ID
NCT05914298
Treatments Being Tested
The goal of this clinical trial is to test the safety and efficacy of local...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2024-01-17
Trial ID
NCT06209099
Treatments Being Tested
For colorectal cancer with peritoneal metastasis, the current first-line st...
Status
Recruiting
Location
Second Affiliated Hospital, Zhejiang University School of Medicine 88 Jiefang Road Hangzhou, Zhejiang 310009, China
Start Date
2026-01
Trial ID
NCT07349043
Treatments Being Tested
Identification and localization of pathological parathyroid gland before pa...
Status
Withdrawn
Location
Haemek Medical Center
Start Date
2018-06-09
Trial ID
NCT03516747
The primary objective of this study is to demonstrate that plasma concentra...
Status
Completed
Location
CHU de Nîmes - Hôpital Universitaire Carémeau
Start Date
2015-06
Trial ID
NCT01736826
Treatments Being Tested
This randomized, single-blind (assessor-blind) controlled trial aims to inv...
Status
Active Not Recruiting
Location
The Second Xiangya Hospital of Central South University
Start Date
2025-05-08
Trial ID
NCT06937476
Treatments Being Tested
HR+/HER2+ breast cancer belongs to a special type of tumor with dual-channe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-20
Trial ID
NCT07300215
Treatments Being Tested